Back to RA CAPITAL MANAGEMENT, L.P.SYRE
SYRE2 quarters
Position history for RA CAPITAL MANAGEMENT, L.P.'s holdings in SPYRE THERAPEUTICS INC
RA CAPITAL MANAGEMENT, L.P. holds 1.6M shares of SYRE (SPYRE THERAPEUTICS INC), worth $81.8M as of 2026-Q1. SYRE represents 0.9% of RA CAPITAL MANAGEMENT, L.P.'s portfolio.
Current Value
$81.8M
Current Shares
1.6M
Total Value Change
+$28.7M
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of SYRE: FMR LLC, BlackRock, Inc., RTW INVESTMENTS, LP